InflaRx NV (IFRX)
1.06
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
1.05
-0.01
(-0.94%)
Pre-Market: 20:00
InflaRx Total Liabilities (Quarterly): 23.25M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.274M |
| LENZ Therapeutics, Inc. | 16.78M |
| Liminatus Pharma, Inc. | 2.988M |
| Oruka Therapeutics, Inc. | 22.46M |
| Maze Therapeutics, Inc. | 42.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.56M |
| Shareholders Equity (Quarterly) | 53.31M |
| Debt to Equity Ratio | 0.0214 |
| Current Ratio | 3.331 |
| Net Debt Paydown Yield | 0.01% |